Deferoxamine Mesylate vs Imatinib

## Deferoxamine Mesylate vs Imatinib: Overview

This comparison examines the pharmacological differences between **Deferoxamine Mesylate** and **Imatinib**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Deferoxamine Mesylate — N/A; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Deferoxamine Mesylate — N/A; Imatinib — C29H31N7O.

**Molecular Weight**: Deferoxamine Mesylate — N/A; Imatinib — 493.6030 g/mol.

**Type**: Deferoxamine Mesylate — Small molecule; Imatinib — Small molecule.